# High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder

> **NCT00297947** · PHASE2,PHASE3 · COMPLETED · sponsor: **Manhattan Psychiatric Center** · enrollment: 60 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** quetiapine
- **DRUG:** quetiapine

## Key facts

- **NCT ID:** NCT00297947
- **Lead sponsor:** Manhattan Psychiatric Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00297947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00297947, "High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00297947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*